| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.52B | -1.1% |
| Cost of Revenue | $500.8M | +12.5% |
| Gross Profit | $2.02B | -3.9% |
| R&D Expense | $732.0M | -20.0% |
| SG&A Expense | $230.5M | -4.4% |
| Operating Income | $689.1M | +41.7% |
| Pre-tax Income | $617.6M | +21.1% |
| Income Tax | $109.2M | +89.9% |
| Net Income | $508.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $891.3M | -32.9% |
| Accounts Receivable | $79.1M | +12.4% |
| Current Assets | $1.19B | -31.5% |
| Total Assets | $2.84B | -14.4% |
| Current Liabilities | $1.89B | +56.4% |
| Total Liabilities | $4.64B | +13.8% |
| Stockholders' Equity | -$1.80B | -138.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $951.8M | +6.5% |
| Capital Expenditures | $21.0M | -6.7% |
| Investing Cash Flow | $111.9M | -74.8% |
| Financing Cash Flow | -$1.53B | -160.9% |
| Free Cash Flow | $930.8M | +6.8% |
| +12.4% |
| EPS (Basic) | $1.89 | +33.1% |
| EPS (Diluted) | $1.86 | +32.9% |